Assessment of risks with acute ischemic stroke in association with CRP levels
Keywords:
CRP, Prognosis, C- reactive protein, NIH Stroke Scale, Risk factors, positive correlationAbstract
Background: There is growing evidence of the prognostic importance of C-reactive protein (CRP) in ischemic stroke. However, the independent value of CRP at different stages after stroke has not been established. Therefore, we assessed the prognostic values of CRP in ischemic stroke. C- reactive protein (CRP), an acute phase reactant and a marker for underlying systemic inflammation has been reported to be elevated in acute coronary syndromes. It has been reported that concentrations of C-reactive protein is directly correlated with the presence and severity of atherosclerosis and are predictors of coronary events and mortality in patients with acute coronary syndromes. Aims and Objectives: The primary aim of this study was to systematically and critically review the relationship between CRP and long-term functional outcome in ischemic stroke patients to evaluate the current state of the literature and also risks involved in it. Materials and methods: This is a prospective study carried out in the Department of Medicine, Shri Sathya Sai Medical College and Research Institute, Ammapettai, Chengalpet, Tamilnadu. Personal history regarding dietary habits, smoking, alcohol consumption and tobacco chewing were noted. NIH Stroke Scale was assessed in all patients to assess the neurological disability and its prognosis.
Downloads
References
Abernethy TJ, Avery OT, The occurrence during acute infections of protein not normally present in the blood. I Distribution of the reactive protein in patients sera and the effect of calcium ions on the flocculation reaction with C-polysaccharide of pneumococcus, J Exp Med 1941; 73:173.
Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155–70.
Amemiya N, Ogawa T, Otsuka K, Ando Y, Nitta K. Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4- year mortality of chronic hemodialysis patients. J Atheroscler Thromb. 2011;18(12):1071–9.
AnuradhaBharosay, KiranSaxena,MeenaVarma , Vivek Vikram Bharosay, AparnaPandey Correlation Between Proinflammatory Serum Markers:High Sensitivity CReactive Protein, Interleukin-6 with Disability Score in Acute Ischemic StrokeInd J ClinBiochem (July-Sept 2011) 26(3):279–282
Brett m. kissela, md janekhouryms et al Epidemiology of Ischemic Stroke in Patients With Diabetes Diabetes Care 28:355–359, 2005.
Calabro P, Golia E, Yeh ET. Role of C-reactive protein in acute myocardial infarction and stroke: possible therapeutic approaches. Curr Pharm Biotechnol. 2012;13(1):4–16.
Clark WM. Cytokines and reperfusion injury. Neurology.1997; 49(suppl 4):10–4.
Di Napoli M. Early inflammatory response in ischemic stroke. Thromb res. 2001:103:261-264.
Gaby C. Kushner I. Acute phase proteins and other systemic responses of inflammation. N Engl J Med 1999; 340: 448-454.
Hertog, H.M.; Rossum, J.A.; Worp, H.B.; Gemert, H.M.; Jonge, R.; Koudstaal, P.J.; Dippel, D.W. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. J. Neurol. 2009, 256, 2003–2008.
Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L. Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the ‘Bergen stroke study’. BMC Neurol. 2009;9:18.
Irene M et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree. The Rotterdam study. stroke 2002:33:2750-5755.
Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132–40.
Lestari, Y. D., Armi, A., Koniasari, K., Setiawan, Y., Sartika, M., Rohmah, H. N. F., Nurpratiwi, Y., & Fahrudin, A. (2022). Effectiveness of the emotional freedom techniques to reducing stress in diabetic patients. International Journal of Health Sciences, 6(2), 555–562. https://doi.org/10.53730/ijhs.v6n2.6728
Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–54.
M.A. Shoaeba, M.A. ShehataCRP in cerebrovascular stroke: Prognostic implications The Egyptian Journal of Critical Care Medicine (2014) 2, 43–52
Maclead CM, Avery OT, The occurrence during acute infections of a protein not normally present in the blood. II Isolation and properties of the reactive protein J. Med. 1941; 73: 183.
Mahapatra SC et al. C-reactive protein in thrombotic stroke JAPI Dec 2002:50:1512.
Mario Di Napoli, Francesca Papa Inflammation, hemostatic markers and antithrombotic agents in relative to long-term risk of new cardiovascular events in first-over ischemic stroke patients. Stroke 2002; 33:1763-1771.
Philip B Gorelick New horizons for stroke prevention: PROGRESS and HOPE THE LANCET Neurology Vol 1 July 2002.
Rathore HS et al. Role of C-reactive protein estimation in early diagnosis of cortical and lacunar infarct. JAPI Dec 2002:1516.
Ridker et al, Inflammation, atherosclerosis, ischemic episode exploring hidden side of the moon”, NEJM 1997, Vol. 336:1014.
Roberta Ravenni, Joe F. Jabre, EdoardoCasiglia Primary stroke prevention and hypertension treatment: which is the first-line strategy? Neurology International 2011; volume 3:e12.
Schaan BD, Pellanda LC, Maciel PT, Duarte ER, Portal VL. C-reactive protein in acute coronary syndrome: association with 3-year outcomes. Braz J Med Biol Res. 2009;42(12):1236–41.
Song, I.U.; Kim, J.S.; Kim, Y.I.; Lee, K.S.; Jeong, D.S.; Chung, S.W. Relationship between high-sensitivityCreactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc. Dis. 2009, 28, 545–550.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Tanne D, Benderly M, Goldbourt U, Hain M, TenenbaumA, et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke.2006; 37:1720–4.
Tillet W.S, Francis T. Serological reactions in pneumoniae with a non-protein somatic fraction of pneumococcus, J. Exp. Med. 1930; 52: 561-571.
Titto T Idicula, Jan BroggerAdmission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study' BMC Neurology 2009, 9:18 doi:10.1186/1471-2377-9-18
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
